Printer Friendly

BIOMERICA'S ULCER TEST APPROVED IN JAPAN

 BIOMERICA'S ULCER TEST APPROVED IN JAPAN
 NEWPORT BEACH, Calif., Sept. 17 /PRNewswire/ -- Biomerica Inc.


(NASDAQ: BMRA) announced that its blood test for ulcer and other gastric ailments, including stomach cancer (H. pylori), has been approved for sale in Japan. The approval came after a year of intensive clinical studies by one of the largest laboratories in Japan using Biomerica's product.
 Being the first to introduce the ulcer test in Japan through a large Japanese firm, Biomerica anticipates significant revenue generated for the current fiscal year.
 Biomerica is a medical company engaged in the development, manufacturing and marketing of advanced medical diagnostic products including home self-testing.
 -0- 9/17/92 R
 /CONTACT: Joseph Irani, president of Biomerica, 714-645-2111/
 (BMRA) CO: Biomerica Inc. ST: California IN: MTC SU: PDT


JB-KJ -- LA001 -- 0614 09/17/92 11:40 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 17, 1992
Words:136
Previous Article:CHEMICAL BANKING $300 MILLION 7.25 PERCENT SUBORDINATED NOTES 'A-' BY FITCH -- FITCH FINANCIAL WIRE --
Next Article:TELETEK ANNOUNCES OPENING OF PURCHASE ESCROW IN ACQUISITION OF INTERSTATE PUBLIC TELEPHONE
Topics:


Related Articles
BIOMERICA SIGNS SALES AGREEMENT WITH INTERNATIONAL MEDICAL COMPANY
BIOMERICA ADDS K-MART FOR DISTRIBUTION OF EZ DETECT TEST
BIOMERICA H. PYLORI TEST SALES SHOULD BENEFIT FROM NIH ANNOUNCEMENT
BIOMERICA H. PYLORI TEST SALES SHOULD BENEFIT FROM NIH ANNOUNCEMENT
BIOMERICA ANNOUNCES FOURTH QUARTER PROFIT
Biomerica Signs New Egyptian Distributor.
Donner Corp. International Issues Speculative Buy Recommendation On Biomerica. Inc.
Biomerica Reports Second Quarter Results.
Biomerica Develops New Test for Detection And Monitoring of Peptic Ulcer and Gastric Cancer.
Biomerica to Produce Diagnostic Products For Worldwide Distribution by ICN Pharmaceuticals.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters